LymphedemaV1, Main, Exploration, bibRecord, 001392

Association Between Time Since Cancer Diagnosis and Health-Related Quality of Life: A Population-Level Analysis

Identifieur interne : 001392 ( Main/Exploration ); précédent : 001391; suivant : 001393

Association Between Time Since Cancer Diagnosis and Health-Related Quality of Life: A Population-Level Analysis

Auteurs : Shi-Yi Wang [États-Unis] ; Sylvia H. Hsu [États-Unis, Canada] ; Cary P. Gross [États-Unis] ; Tara Sanft [États-Unis] ; Amy J. Davidoff [États-Unis] ; Xiaomei Ma [États-Unis] ; James B. Yu [États-Unis]

Source :

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [ 1098-3015 ] ; 2016.

RBID : PMC:5002308

Abstract

Objectives

To examine the association between time since cancer diagnosis and health-related quality of life (HRQOL) among cancer survivors in remission.

Methods

Analyzing data from 3,610 cancer survivors and 59,539 individuals without cancer in the Medical Expenditure Panel Survey, we examined the relationship between time since cancer diagnosis and HRQOL, taking remission status into account and controlling for patient demographics and comorbidities. HRQOL measurements included the six-dimensional health state short form (SF-6D) utility scores, the Physical Component Summary (PCS), and the Mental Component Summary (MCS).

Results

The relation between the time since cancer diagnosis and HRQOL varied substantially across cancer types. Compared with individuals without cancer, survivors of breast, prostate, or poor-prognosis cancer had statistically lower SF-6D scores within 2 years of diagnosis (-0.044, −0.062, and −0.088, respectively). Breast cancer survivors had SF-6D scores similar to non-cancer individuals after 2 years, as did patients with poor-prognosis cancer after 5 years. However, even after a period of 10 years, survivors of prostate or cervical cancer had a lower level of SF-6D scores (−0.027 and −0.042, respectively). The comparisons of physical health between cancer survivors and individuals without cancer were similar to those of SF-6D. In contrast, most cancer survivors did not experience poorer mental health; however, survivors of prostate or cervical cancer had lower MCS after 10 years of diagnosis.

Conclusions

The level of HRQOL among cancer survivors depends on time since cancer diagnosis and cancer type. Some cancer survivors have lower HRQOL after a decade of diagnosis, even in remission.

Url:

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002308

DOI: 10.1016/j.jval.2016.02.010
PubMed: 27565280
PubMed Central: 5002308

Affiliations:

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Association Between Time Since Cancer Diagnosis and Health-Related Quality of Life: A Population-Level Analysis</title>
<author><name sortKey="Wang, Shi Yi" sort="Wang, Shi Yi" uniqKey="Wang S" first="Shi-Yi" last="Wang">Shi-Yi Wang</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A2">Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, Connecticut, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hsu, Sylvia H" sort="Hsu, Sylvia H" uniqKey="Hsu S" first="Sylvia H." last="Hsu">Sylvia H. Hsu</name>
<affiliation wicri:level="2"><nlm:aff id="A2">Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, Connecticut, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="A3">Schulich School of Business, York University, Toronto, Ontario, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Schulich School of Business, York University, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gross, Cary P" sort="Gross, Cary P" uniqKey="Gross C" first="Cary P." last="Gross">Cary P. Gross</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A4">Section of General Internal Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Section of General Internal Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sanft, Tara" sort="Sanft, Tara" uniqKey="Sanft T" first="Tara" last="Sanft">Tara Sanft</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A5">Section of Medical Oncology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Section of Medical Oncology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Davidoff, Amy J" sort="Davidoff, Amy J" uniqKey="Davidoff A" first="Amy J." last="Davidoff">Amy J. Davidoff</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A6">Department of Health Policy and Management, Yale University School of Public Health, New Haven, Connecticut</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Connecticut</region>
</placeName>
<wicri:cityArea>Department of Health Policy and Management, Yale University School of Public Health, New Haven</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Ma, Xiaomei" sort="Ma, Xiaomei" uniqKey="Ma X" first="Xiaomei" last="Ma">Xiaomei Ma</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A2">Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, Connecticut, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Yu, James B" sort="Yu, James B" uniqKey="Yu J" first="James B." last="Yu">James B. Yu</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A7">Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">27565280</idno>
<idno type="pmc">5002308</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5002308</idno>
<idno type="RBID">PMC:5002308</idno>
<idno type="doi">10.1016/j.jval.2016.02.010</idno>
<date when="2016">2016</date>
<idno type="wicri:Area/Pmc/Corpus">003415</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">003415</idno>
<idno type="wicri:Area/Pmc/Curation">003414</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">003414</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000B78</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000B78</idno>
<idno type="wicri:Area/Ncbi/Merge">008737</idno>
<idno type="wicri:Area/Ncbi/Curation">008737</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">008737</idno>
<idno type="wicri:doubleKey">1098-3015:2016:Wang S:association:between:time</idno>
<idno type="wicri:Area/Main/Merge">001394</idno>
<idno type="wicri:Area/Main/Curation">001392</idno>
<idno type="wicri:Area/Main/Exploration">001392</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Association Between Time Since Cancer Diagnosis and Health-Related Quality of Life: A Population-Level Analysis</title>
<author><name sortKey="Wang, Shi Yi" sort="Wang, Shi Yi" uniqKey="Wang S" first="Shi-Yi" last="Wang">Shi-Yi Wang</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A2">Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, Connecticut, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Hsu, Sylvia H" sort="Hsu, Sylvia H" uniqKey="Hsu S" first="Sylvia H." last="Hsu">Sylvia H. Hsu</name>
<affiliation wicri:level="2"><nlm:aff id="A2">Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, Connecticut, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
<affiliation wicri:level="1"><nlm:aff id="A3">Schulich School of Business, York University, Toronto, Ontario, Canada</nlm:aff>
<country xml:lang="fr">Canada</country>
<wicri:regionArea>Schulich School of Business, York University, Toronto, Ontario</wicri:regionArea>
<wicri:noRegion>Ontario</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Gross, Cary P" sort="Gross, Cary P" uniqKey="Gross C" first="Cary P." last="Gross">Cary P. Gross</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A4">Section of General Internal Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Section of General Internal Medicine, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sanft, Tara" sort="Sanft, Tara" uniqKey="Sanft T" first="Tara" last="Sanft">Tara Sanft</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A5">Section of Medical Oncology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Section of Medical Oncology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Davidoff, Amy J" sort="Davidoff, Amy J" uniqKey="Davidoff A" first="Amy J." last="Davidoff">Amy J. Davidoff</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A6">Department of Health Policy and Management, Yale University School of Public Health, New Haven, Connecticut</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<placeName><region type="state">Connecticut</region>
</placeName>
<wicri:cityArea>Department of Health Policy and Management, Yale University School of Public Health, New Haven</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Ma, Xiaomei" sort="Ma, Xiaomei" uniqKey="Ma X" first="Xiaomei" last="Ma">Xiaomei Ma</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A2">Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, Connecticut, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Chronic Disease Epidemiology, Yale University School of Public Health, New Haven, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Yu, James B" sort="Yu, James B" uniqKey="Yu J" first="James B." last="Yu">James B. Yu</name>
<affiliation wicri:level="2"><nlm:aff id="A1">Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Cancer Outcomes, Public Policy, and Effectiveness Research (COPPER) Center, Yale Cancer Center and Yale University School of Medicine, New Haven, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
<affiliation wicri:level="2"><nlm:aff id="A7">Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut, USA</nlm:aff>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Therapeutic Radiology, Yale University School of Medicine, New Haven, Connecticut</wicri:regionArea>
<placeName><region type="state">Connecticut</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research</title>
<idno type="ISSN">1098-3015</idno>
<idno type="eISSN">1524-4733</idno>
<imprint><date when="2016">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><sec id="S1"><title>Objectives</title>
<p id="P2">To examine the association between time since cancer diagnosis and health-related quality of life (HRQOL) among cancer survivors in remission.</p>
</sec>
<sec id="S2"><title>Methods</title>
<p id="P3">Analyzing data from 3,610 cancer survivors and 59,539 individuals without cancer in the Medical Expenditure Panel Survey, we examined the relationship between time since cancer diagnosis and HRQOL, taking remission status into account and controlling for patient demographics and comorbidities. HRQOL measurements included the six-dimensional health state short form (SF-6D) utility scores, the Physical Component Summary (PCS), and the Mental Component Summary (MCS).</p>
</sec>
<sec id="S3"><title>Results</title>
<p id="P4">The relation between the time since cancer diagnosis and HRQOL varied substantially across cancer types. Compared with individuals without cancer, survivors of breast, prostate, or poor-prognosis cancer had statistically lower SF-6D scores within 2 years of diagnosis (-0.044, −0.062, and −0.088, respectively). Breast cancer survivors had SF-6D scores similar to non-cancer individuals after 2 years, as did patients with poor-prognosis cancer after 5 years. However, even after a period of 10 years, survivors of prostate or cervical cancer had a lower level of SF-6D scores (−0.027 and −0.042, respectively). The comparisons of physical health between cancer survivors and individuals without cancer were similar to those of SF-6D. In contrast, most cancer survivors did not experience poorer mental health; however, survivors of prostate or cervical cancer had lower MCS after 10 years of diagnosis.</p>
</sec>
<sec id="S4"><title>Conclusions</title>
<p id="P5">The level of HRQOL among cancer survivors depends on time since cancer diagnosis and cancer type. Some cancer survivors have lower HRQOL after a decade of diagnosis, even in remission.</p>
</sec>
</div>
</front>
</TEI>
<affiliations><list><country><li>Canada</li>
<li>États-Unis</li>
</country>
<region><li>Connecticut</li>
</region>
</list>
<tree><country name="États-Unis"><region name="Connecticut"><name sortKey="Wang, Shi Yi" sort="Wang, Shi Yi" uniqKey="Wang S" first="Shi-Yi" last="Wang">Shi-Yi Wang</name>
</region>
<name sortKey="Davidoff, Amy J" sort="Davidoff, Amy J" uniqKey="Davidoff A" first="Amy J." last="Davidoff">Amy J. Davidoff</name>
<name sortKey="Davidoff, Amy J" sort="Davidoff, Amy J" uniqKey="Davidoff A" first="Amy J." last="Davidoff">Amy J. Davidoff</name>
<name sortKey="Gross, Cary P" sort="Gross, Cary P" uniqKey="Gross C" first="Cary P." last="Gross">Cary P. Gross</name>
<name sortKey="Gross, Cary P" sort="Gross, Cary P" uniqKey="Gross C" first="Cary P." last="Gross">Cary P. Gross</name>
<name sortKey="Hsu, Sylvia H" sort="Hsu, Sylvia H" uniqKey="Hsu S" first="Sylvia H." last="Hsu">Sylvia H. Hsu</name>
<name sortKey="Ma, Xiaomei" sort="Ma, Xiaomei" uniqKey="Ma X" first="Xiaomei" last="Ma">Xiaomei Ma</name>
<name sortKey="Ma, Xiaomei" sort="Ma, Xiaomei" uniqKey="Ma X" first="Xiaomei" last="Ma">Xiaomei Ma</name>
<name sortKey="Sanft, Tara" sort="Sanft, Tara" uniqKey="Sanft T" first="Tara" last="Sanft">Tara Sanft</name>
<name sortKey="Sanft, Tara" sort="Sanft, Tara" uniqKey="Sanft T" first="Tara" last="Sanft">Tara Sanft</name>
<name sortKey="Wang, Shi Yi" sort="Wang, Shi Yi" uniqKey="Wang S" first="Shi-Yi" last="Wang">Shi-Yi Wang</name>
<name sortKey="Yu, James B" sort="Yu, James B" uniqKey="Yu J" first="James B." last="Yu">James B. Yu</name>
<name sortKey="Yu, James B" sort="Yu, James B" uniqKey="Yu J" first="James B." last="Yu">James B. Yu</name>
</country>
<country name="Canada"><noRegion><name sortKey="Hsu, Sylvia H" sort="Hsu, Sylvia H" uniqKey="Hsu S" first="Sylvia H." last="Hsu">Sylvia H. Hsu</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001392 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001392 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     PMC:5002308
   |texte=   Association Between Time Since Cancer Diagnosis and Health-Related Quality of Life: A Population-Level Analysis
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:27565280" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

Serveur d'exploration sur le lymphœdème

Association Between Time Since Cancer Diagnosis and Health-Related Quality of Life: A Population-Level Analysis

Association Between Time Since Cancer Diagnosis and Health-Related Quality of Life: A Population-Level Analysis

Source :

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki

	Serveur d'exploration sur le lymphœdème
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.